The DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.
Acinetobacter baumannii : Emergence of a Successful Pathogen
Open accessAbstract
SUMMARY: Acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions globally. As a consequence of its immense ability to acquire or upregulate antibiotic drug resistance determinants, it has justifiably been propelled to the forefront of scientific attention. Apart from its predilection for the seriously ill within intensive care units, A. baumannii has more recently caused a range of infectious syndromes in military personnel injured in the Iraq and Afghanistan conflicts. This review details the significant advances that have been made in our understanding of this remarkable organism over the last 10 years, including current taxonomy and species identification, issues with susceptibility testing, mechanisms of antibiotic resistance, global epidemiology, clinical impact of infection, host-pathogen interactions, and infection control and therapeutic considerations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Bergey's Manual of Determinative Bacteriology
S., F. A., Buchanan, R. E. T., Gibbons, N. E., & Bergey (1975) · Taxon · doi:10.2307/1218353 · Cited by 11,333
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Self-citationMaiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., Caugant, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3140 · Cited by 3,833
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Approved Lists of Bacterial Names
SKERMAN, V. B. D., SNEATH, P. H. A., & McGOWAN, V. (1980) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-30-1-225 · Cited by 2,604
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308 · cited 1×
“Dosing varies greatly between studies, but according to the Infectious Diseases Society of America, 5 mg of polymyxin B or 10 mg of colistin daily is recommended for adults (553).”
BackgroundInadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404 · cited 4×
“6% of ICU-acquired UTIs in one study (187).”
BackgroundInfluentialColistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Self-citationAcute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344
APACHE II-A Severity of Disease Classification System
Gall, J.-R. L., Loirat, P., & Alpcrovitch, A. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00027 · Cited by 1,236
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 2×
“Unfortunately, progress has been slow, with agents such as phenyl-arginine-naphthylamide doing well when assessed in vitro but coming to demise due to toxicity concerns (433).”
BackgroundSOS response promotes horizontal dissemination of antibiotic resistance genes
Beaber, J. W., Hochhut, B., & Waldor, M. K. (2004) · Nature · doi:10.1038/nature02241 · Cited by 1,186
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., & Rodríguez-Valera, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4382-4390.2005 · Cited by 662
Self-citationTurton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E., & Pitt, T. L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01021-06 · Cited by 657
Rahal, J. J. (1998) · JAMA · doi:10.1001/jama.280.14.1233 · Cited by 642
Bouvet, P. J. M., & Grimont, P. A. D. (1986) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-36-2-228 · Cited by 632
Levin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
Tomaras, A. P., Dorsey, C. W., Edelmann, R. E., & Actis, L. A. (2003) · Microbiology · doi:10.1099/mic.0.26541-0 · Cited by 599
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00001 · Cited by 580
Setting and Revising Antibacterial Susceptibility Breakpoints
Turnidge, J., & Paterson, D. L. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-06 · Cited by 578
Self-citationInhibition of Mutation and Combating the Evolution of Antibiotic Resistance
Cirz, R. T., Chin, J. K., Andes, D. R., de Crécy-Lagard, V., Craig, W. A., & Romesberg, F. E. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030176 · Cited by 576
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
16S Ribosomal RNA Methylation: Emerging Resistance Mechanism against Aminoglycosides
Doi, Y., & Arakawa, Y. (2007) · Clinical Infectious Diseases · doi:10.1086/518605 · Cited by 571
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Lodise, T. P., Lomaestro, B., & Drusano, G. L. (2007) · Clinical Infectious Diseases · doi:10.1086/510590 · Cited by 527
Evaluation of the DNA fingerprinting method AFLP as a new tool in bacterial taxonomy
Janssen, P., Coopman, R., Huys, G., Swings, J., Bleeker, M., Vos, P., Zabeau, M., & Kersters, K. (1996) · Microbiology · doi:10.1099/13500872-142-7-1881 · Cited by 525
Lee, K., Lim, Y. S., Yong, D., Yum, J. H., & Chong, Y. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4623-4629.2003 · Cited by 514
Hujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-06 · Cited by 480
Self-citationSmith, M. G., Gianoulis, T. A., Pukatzki, S., Mekalanos, J. J., Ornston, L. N., Gerstein, M., & Snyder, M. (2007) · Genes & Development · doi:10.1101/gad.1510307 · Cited by 474
Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 470
Survival of Acinetobacter baumannii on Dry Surfaces: Comparison of Outbreak and Sporadic Isolates
Jawad, A., Seifert, H., Snelling, A. M., Heritage, J., & Hawkey, P. M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.1938-1941.1998 · Cited by 464
Self-citationLomovskaya, O., & Bostian, K. A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.008 · Cited by 460
Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy
Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., Gomes, D. R. J., Dasbach, E. J., & Platt, R. (2001) · Clinical Infectious Diseases · doi:10.1086/319211 · Cited by 451
Antibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Vila, J., Martí, S., & Sánchez-Céspedes, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl509 · Cited by 436
Ventre, I., Goodman, A. L., Vallet-Gely, I., Vasseur, P., Soscia, C., Molin, S., Bleves, S., Lazdunski, A., Lory, S., & Filloux, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507407103 · Cited by 428
Messing with Bacterial Quorum Sensing
González, J. E., & Keshavan, N. D. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00002-06 · Cited by 425
Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P. E., & Testa, R. T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.738 · Cited by 415
Ellis‐Grosse, E. J., Babinchak, T., Dartois, N., Rose, G., Loh, E., & Groups, T. 3. A. 3. C. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431675 · Cited by 414
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Sunenshine, R. H., Wright, M.-O., Maragakis, L. L., Harris, A. D., Song, X., Hebden, J., Cosgrove, S. E., Anderson, A., Carnell, J., Jernigan, D. B., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060716 · Cited by 411
Marchand, I., Damier-Piolle, L., Courvalin, P., & Lambert, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3298-3304.2004 · Cited by 407
Acinetobacter Outbreaks, 1977–2000
Villegas, M. V., & Hartstein, A. I. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502205 · Cited by 402
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Falagas, M. E., & Bliziotis, I. A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.12.012 · Cited by 393
Scott, P., Deye, G., Srinivasan, A., Murray, C., Moran, K., Hulten, E., Fishbain, J., Craft, D., Riddell, S., Lindler, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518170 · Cited by 393
Gales, A. C., Reis, A. O., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.183-190.2001 · Cited by 382
Babinchak, T., Ellis‐Grosse, E., Dartois, N., Rose, G. M., Loh, E., & Groups, T. 3. A. 3. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431676 · Cited by 381
Go, E. S., Urban, C., Burns, J., Mariano, N., Mosinka-Snipas, K., Rahal, J. J., Kreiswirth, B., & Eisner, W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90694-7 · Cited by 369
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
Corbella, X., Montero, A., Pujol, M., Domínguez, M. A., Ayats, J., Argerich, M. J., Garrigosa, F., Ariza, J., & Gudiol, F. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4086-4095.2000 · Cited by 348
Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Findings, and Prognostic Features
Cisneros, J. M., Reyes, M. J., Pachon, J., Becerril, B., Caballero, F. J., Garcia Garmendia, J. L., Ortiz, C., & Cobacho, A. R. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.6.1026 · Cited by 342
Demar, M., Ajzenberg, D., Maubon, D., Djossou, F., Panchoe, D., Punwasi, W., Valery, N., Peneau, C., Daigre, J.-L., Aznar, C., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/521246 · Cited by 338
Lee, K., Yum, J. H., Yong, D., Lee, H. M., Kim, H. D., Docquier, J.-D., Rossolini, G. M., & Chong, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4485-4491.2005 · Cited by 333
Isolation of Acinetobacter from Soil and Water
Baumann, P. (1968) · Journal of Bacteriology · doi:10.1128/jb.96.1.39-42.1968 · Cited by 330
Antimicrobial resistance of Acinetobacter spp. in Europe
Van Looveren, M., & Goossens, H. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00942.x · Cited by 327
Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
Davis, K. A., Moran, K. A., McAllister, C. K., & Gray, P. J. (2005) · Emerging Infectious Diseases · doi:10.3201/1108.050103 · Cited by 327
Seifert, H., Dijkshoorn, L., Gerner-Smidt, P., Pelzer, N., Tjernberg, I., & Vaneechoutte, M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.11.2819-2825.1997 · Cited by 322
Self-citationIdentification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis
Vaneechoutte, M., Dijkshoorn, L., Tjernberg, I., Elaichouni, A., de Vos, P., Claeys, G., & Verschraegen, G. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.1.11-15.1995 · Cited by 313
Manikal, V. M., Landman, D., Saurina, G., Oydna, E., Lal, H., & Quale, J. (2000) · Clinical Infectious Diseases · doi:10.1086/313902 · Cited by 309
Gales, A. C., Jones, R. N., & Sader, H. S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01351.x · Cited by 302
Landman, D., Quale, J. M., Mayorga, D., Adedeji, A., Vangala, K., Ravishankar, J., Flores, C., & Brooks, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.13.1515 · Cited by 301
Choi, C. H., Lee, E. Y., Lee, Y. C., Park, T. I., Kim, H. J., Hyun, S. H., Kim, S. A., Lee, S.-K., & Lee, J. C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00538.x · Cited by 301
Michalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S., & Falagas, M. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01043.x · Cited by 292
Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii
Héritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4174-4179.2005 · Cited by 286
Multidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Markou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I., & Gregorakos, L. (2003) · Critical Care · doi:10.1186/cc2358 · Cited by 278
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings
Garnacho-Montero, J., Ortiz-Leyba, C., Fernández-Hinojosa, E., Aldabó-Pallás, T., Cayuela, A., Marquez-Vácaro, J. A., Garcia-Curiel, A., & Jiménez-Jiménez, F. J. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2598-0 · Cited by 276
Infectious Complications of Open Type III Tibial Fractures among Combat Casualties
Johnson, E. N., Burns, T. C., Hayda, R. A., Hospenthal, D. R., & Murray, C. K. (2007) · Clinical Infectious Diseases · doi:10.1086/520029 · Cited by 276
Mussi, M. A., Limansky, A. S., & Viale, A. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1432-1440.2005 · Cited by 276
Antoniadou, A., Kontopidou, F., Poulakou, G., Koratzanis, E., Galani, I., Papadomichelakis, E., Kopterides, P., Souli, M., Armaganidis, A., & Giamarellou, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl562 · Cited by 273
Falagas, M. E., Bliziotis, I. A., & Siempos, I. I. (2006) · Critical Care · doi:10.1186/cc4869 · Cited by 272
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Biofilm formation by Acinetobacter baumannii.
Vidal, R., Domínguez, M., Urrutia, H., Bello, H., González, G., García, A., & Raúl Zemelman, Z. (1996) · PubMed · Cited by 271
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
Ko, K. S., Suh, J. Y., Kwon, K. T., Jung, S.-I., Park, K.-H., Kang, C. I., Chung, D. R., Peck, K. R., & Song, J.-H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm305 · Cited by 262
Aerosol Polymyxin and Pneumonia in Seriously Ill Patients
Feeley, T. W., du Moulin, G. C., Hedley-Whyte, J., Bushnell, L. S., Gilbert, J. P., & Feingold, D. S. (1975) · New England Journal of Medicine · doi:10.1056/nejm197509042931003 · Cited by 261
Seifert, H., Strate, A., & Pulverer, G. (1995) · Medicine · doi:10.1097/00005792-199511000-00004 · Cited by 259
Self-citationNovel Pseudomonas aeruginosa Quorum-Sensing Inhibitors Identified in an Ultra-High-Throughput Screen
Müh, U., Schuster, M., Heim, R., Singh, A., Olson, E. R., & Greenberg, E. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00665-06 · Cited by 259
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii
Peleg, A. Y., Adams, J., & Paterson, D. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-06 · Cited by 257
Self-citationImproved antimicrobial peptides based on acyl-lysine oligomers
Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2007) · Nature Biotechnology · doi:10.1038/nbt1309 · Cited by 256
Eradication of early Pseudomonas aeruginosa infection
Høiby, N., Frederiksen, B., & Pressler, T. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2005.05.018 · Cited by 255
Playford, E. G., Craig, J. C., & Iredell, J. R. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.11.010 · Cited by 251
Feil, E. J., Smith, J. M., Enright, M. C., & Spratt, B. G. (2000) · Genetics · doi:10.1093/genetics/154.4.1439 · Cited by 250
Riccio, M. L., Franceschini, N., Boschi, L., Caravelli, B., Cornaglia, G., Fontana, R., Amicosante, G., & Rossolini, G. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1229-1235.2000 · Cited by 249
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Peleg, A. Y., Potoski, B. A., Rea, R., Adams, J., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248
Self-citationBou, G., Oliver, A., & Martínez-Beltrán, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1556-1561.2000 · Cited by 247
INFECTIONS WITH ACINETOBACTER CALCOACETICUS (HERELLEA VAGINICOLA): CLINICAL AND LABORATORY STUDIES
GLEW, R. H., MOELLERING, R. C., & KUNZ, L. J. (1977) · Medicine · doi:10.1097/00005792-197703000-00001 · Cited by 245
ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S., & Amyes, S. G. B. (1993) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(93)90045-7 · Cited by 245
Lo-Ten-Foe, J. R., de Smet, A. M. G. A., Diederen, B. M. W., Kluytmans, J. A. J. W., & van Keulen, P. H. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01406-06 · Cited by 242
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
Falagas, M. E., Rizos, M., Bliziotis, I. A., Rellos, K., Kasiakou, S. K., & Michalopoulos, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-1 · Cited by 242
Ruzin, A., Keeney, D., & Bradford, P. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm058 · Cited by 238
Vahaboglu, H., Oztürk, R., Aygün, G., Coşkunkan, F., Yaman, A., Kaygusuz, A., Leblebicioglu, H., Balik, I., Aydin, K., & Otkun, M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2265 · Cited by 236
Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., & Nordmann, P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3542-3547.2003 · Cited by 235
Wisplinghoff, H., Edmond, M. B., Pfaller, M. A., Jones, R. N., Wenzel, R. P., & Seifert, H. (2000) · Clinical Infectious Diseases · doi:10.1086/314040 · Cited by 235
Self-citationDonald, H. M., Scaife, W., Amyes, S. G. B., & Young, H.-K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.196-199.2000 · Cited by 235
The Antibiotic Pipeline — Challenges, Costs, and Values
Wenzel, R. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048093 · Cited by 230
Fernandez-Cuenca, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg097 · Cited by 229
Franklin, C., Liolios, L., & Peleg, A. Y. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00879-06 · Cited by 227
Self-citationBohnert, J. A., & Kern, W. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.849-852.2005 · Cited by 226
Nemec, A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45716-0 · Cited by 226
Brown, S., Young, H. K., & Amyes, S. G. B. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01016.x · Cited by 225
Trauma-related Infections in Battlefield Casualties From Iraq
Petersen, K., Riddle, M. S., Danko, J. R., Blazes, D. L., Hayden, R., Tasker, S. A., & Dunne, J. R. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251707.32332.c1 · Cited by 222
Nicas, T. I., & Hancock, R. E. W. (1980) · Journal of Bacteriology · doi:10.1128/jb.143.2.872-878.1980 · Cited by 221
Urban, C., Segal‐Maurer, S., & Rahal, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/374847 · Cited by 211
Michalopoulos, A., Kasiakou, S. K., Mastora, Z., Rellos, K., Kapaskelis, A. M., & Falagas, M. E. (2004) · Critical Care · doi:10.1186/cc3020 · Cited by 209
Lolans, K., Rice, T. W., Munoz-Price, L. S., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-06 · Cited by 202
Jawad, A., Heritage, J. C., Snelling, A. M., Gascoyne‐Binzi, D., & Hawkey, P. M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2881-2887.1996 · Cited by 202
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
Kuti, J. L., Dandekar, P. K., Nightingale, C. H., & Nicolau, D. P. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257225 · Cited by 199
Thomas, L., Maillard, J.-Y., Lambert, R. J. W., & Russell, A. D. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.2000.0851 · Cited by 199
Simor, A. E., Lee, M., Vearncombe, M., Jones-Paul, L., Barry, C., Gomez, M., Fish, J. S., Cartotto, R. C., Palmer, R., & Louie, M. (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/502046 · Cited by 198
Tam, V. H., Schilling, A. N., Neshat, S., Poole, K., Melnick, D. A., & Coyle, E. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4920-4927.2005 · Cited by 196
Landman, D., Bratu, S., Kochar, S., Panwar, M., Trehan, M., Doymaz, M., & Quale, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm129 · Cited by 192
Kwa, A. L. H., Loh, C., Low, J. G. H., Kurup, A., & Tam, V. H. (2005) · Clinical Infectious Diseases · doi:10.1086/432583 · Cited by 191
Coelho, J. M., Turton, J. F., Kaufmann, M. E., Glover, J., Woodford, N., Warner, M., Palepou, M.-F., Pike, R., Pitt, T. L., Patel, B. C., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00699-06 · Cited by 191
Fulminant Community-Acquired Acinetobacter baumannii Pneumonia as a Distinct Clinical Syndrome
Leung, W.-S., Chu, C.-M., Tsang, K.-Y., Lo, F.-H., Lo, K.-F., & Ho, P.-L. (2006) · Chest · doi:10.1378/chest.129.1.102 · Cited by 190
OXA β-lactamases in Acinetobacter: the story so far
Brown, S., & Amyes, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki425 · Cited by 189
GUARDABASSI, L., DIJKSHOORN, L., COLLARD, J.-M., OLSEN, J. E., & DALSGAARD, A. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-10-929 · Cited by 189
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
Kwon, K. T., Oh, W. S., Song, J.-H., Chang, H.-H., Jung, S.-I., Kim, S.-W., Ryu, S. Y., Heo, S. T., Jung, D. S., Rhee, J.-Y., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl499 · Cited by 188
Ouderkirk, J. P., Nord, J. A., Turett, G. S., & Kislak, J. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2659-2662.2003 · Cited by 188
Reina, R., Estenssoro, E., Sáenz, G., Canales, H. S., Gonzalvo, R., Vidal, G., Martins, G., Das Neves, A., Santander, O., & Ramos, C. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2691-4 · Cited by 186
Döring, G., Meisner, C., Stern, M., & for the Flagella Vaccine Trial Study Group (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702403104 · Cited by 186
Cameron, A. D., Ridderström, M., Olin, B., & Mannervik, B. (1999) · Structure · doi:10.1016/s0969-2126(99)80174-9 · Cited by 184
Suller, M. T. E., & Russell, A. D. (1999) · Journal of Hospital Infection · doi:10.1016/s0195-6701(99)90424-3 · Cited by 180
Differential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia
Knapp, S., Wieland, C. W., Florquin, S., Pantophlet, R., Dijkshoorn, L., Tshimbalanga, N., Akira, S., & van der Poll, T. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-730oc · Cited by 180
Blot, S., Vandewoude, K., & Colardyn, F. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1648-8 · Cited by 177
Community-Acquired Acinetobacter Pneumonia in the Northern Territory of Australia
Anstey, N. M., Currie, B. J., & Withnall, K. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.83 · Cited by 176
Bacteriology of War Wounds at the Time of Injury
Murray, C. K., Roop, S. A., Hospenthal, D. R., Dooley, D. P., Wenner, K., Hammock, J., Taufen, N., & Gourdine, E. (2006) · Military Medicine · doi:10.7205/milmed.171.9.826 · Cited by 176
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Owen, R. J., Li, J., Nation, R. L., & Spelman, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl512 · Cited by 176
Surveillance Cultures and Duration of Carriage of Multidrug-Resistant Acinetobacter baumannii
Marchaim, D., Navon-Venezia, S., Schwartz, D., Tarabeia, J., Fefer, I., Schwaber, M. J., & Carmeli, Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02424-06 · Cited by 175
Risk Factors for Acquisition of Imipenem-Resistant Acinetobacter baumannii : a Case-Control Study
Lee, S.-O., Kim, N. J., Choi, S.-H., Kim, T. H., Chung, J.-W., Woo, J.-H., Ryu, J., & Kim, Y. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.224-228.2004 · Cited by 175
Rice, L. B. (2006) · Clinical Infectious Diseases · doi:10.1086/504487 · Cited by 175
Wood, G. C., Hanes, S. D., Croce, M. A., Fabian, T. C., & Boucher, B. A. (2002) · Clinical Infectious Diseases · doi:10.1086/340055 · Cited by 174
Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients
Li, C., Kuti, J. L., Nightingale, C. H., & Nicolau, D. P. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006291035 · Cited by 171
Discrimination of Acinetobacter Genomic Species by AFLP Fingerprinting
Janssen, P., Maquelin, K., Coopman, R., Tjernberg, I., Bouvet, P., Kersters, K., & Dijkshoorn, L. (1997) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-47-4-1179 · Cited by 167
Distribution of Acinetobacter Species on Skin of Healthy Humans
Aucken, H., Berlau, J., Malnick, H., & Pitt, T. (1999) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050254 · Cited by 166
Motaouakkil, S., Charra, B., Hachimi, A., Nejmi, H., Benslama, A., Elmdaghri, N., Belabbes, H., & Benbachir, M. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.11.019 · Cited by 165
Urban, C., Go, E., Mariano, N., Berger, B. J., Avraham, I., Rubin, D., & Rahal, J. J. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.2.448 · Cited by 164
Kaye, K. S., Harris, A. D., Samore, M. H., & Carmeli, Y. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502550 · Cited by 163
Yum, J. H. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf043 · Cited by 163
Ecker, J. A., Massire, C., Hall, T. A., Ranken, R., Pennella, T.-T. D., Agasino Ivy, C., Blyn, L. B., Hofstadler, S. A., Endy, T. P., Scott, P. T., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00619-06 · Cited by 163
Acinetobacter radioresistens sp. nov. Isolated from Cotton and Soil
Nishimura, Y., Ino, T., & Iizuka, H. (1988) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-38-2-209 · Cited by 160
Levin, A. S., Levy, C. E., Manrique, A. E. I., Medeiros, E. A. S., & Costa, S. F. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00276-5 · Cited by 159
Gram-Negative Outer and Inner Membrane Models: Insertion of Cyclic Cationic Lipopeptides
Clausell, A., Garcia-Subirats, M., Pujol, M., Busquets, M. A., Rabanal, F., & Cajal, Y. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp064757+ · Cited by 159
Garnacho, J., Sole-Violan, J., Sa-Borges, M., Diaz, E., & Rello, J. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000089936.09573.f3 · Cited by 159
Montero, A., Ariza, J., Corbella, X., Doménech, A., Cabellos, C., Ayats, J., Tubau, F., Borraz, C., & Gudiol, F. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh485 · Cited by 158
Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells
Lee, J. C., Koerten, H. K., van den Broek, P., Beekhuizen, H., Wolterbeek, R., van den Barselaar, M., van der Reijden, T., van der Meer, J., van de Gevel, J. S., & Dijkshoorn, L. (2005) · Research in Microbiology · doi:10.1016/j.resmic.2005.09.011 · Cited by 157
Poirel, L., Karim, A., Mercat, A., Thomas, I., Vahaboğlu, H., Richard, C., & Nordmann, P. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.157 · Cited by 156
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
Berlana, D., Llop, J. M., Casamartina, E. F., Badia, M., & Jódar, R. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.1.39 · Cited by 155
Is IS ABA-1 customized for Acinetobacter ?
Segal, H., Garny, S., & Elisha, B. G. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.01.005 · Cited by 153
Moraxella, Acinetobacter, and the Mimeae
HENRIKSEN, S. D. (1973) · Bacteriological Reviews · doi:10.1128/br.37.4.522-561.1973 · Cited by 151
Falagas, M. E., Bliziotis, I. A., & Tam, V. H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.024 · Cited by 151
Montero, A., Ariza, J., Corbella, X., Domenech, A., Cabellos, C., Ayats, J., Tubau, F., Ardanuy, C., & Gudiol, F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1946-1952.2002 · Cited by 151
Vaneechoutte, M., Young, D. M., Ornston, L. N., Baere, T. D., Nemec, A., van der Reijden, T., Carr, E. L., Tjernberg, I., & Dijkshoorn, L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.1.932-936.2006 · Cited by 149
Jaruratanasirikul, S., Sriwiriyajan, S., & Punyo, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1337-1339.2005 · Cited by 149
Sobieszczyk, M. E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh369 · Cited by 147
Yamamoto, S., Okujo, N., & Sakakibara, Y. (1994) · Archives of Microbiology · doi:10.1007/bf00301846 · Cited by 147
Anstey, N. M., Currie, B. J., Hassell, M., Palmer, D., Dwyer, B., & Seifert, H. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.2.685-686.2002 · Cited by 146
Self-citationTurton, J. F., Kaufmann, M. E., Glover, J., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3074-3082.2005 · Cited by 146
Me, J.-M., Pichardo-Guerrero, C., Márquez-Rivas, J., Martín-Lozano, D., Prados, T., & Pachón, J. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-001-0680-2 · Cited by 145
Seasonal Variation of Acinetobacter Infections: 1987-1996
McDonald, L. C., Banerjee, S. N., Jarvis, W. R., & System, N. N. I. S. (1999) · Clinical Infectious Diseases · doi:10.1086/313441 · Cited by 145
Trends in antimicrobial drug development: Implications for the future
Sergio Mella, M. (2005) · Revista chilena de infectología · doi:10.4067/s0716-10182005000200011 · Cited by 144
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1586-1592.2004 · Cited by 142
Self-citationBetrosian, A. P., Frantzeskaki, F. G., Xanthaki, A., & Georgiadis, G. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600951184 · Cited by 138
Pharmacokinetics of Sulbactam/Ampicillin in Humans: A Review
Foulds, G. H. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.supplement_5.503 · Cited by 137
Dorsey, C. W., Tomaras, A. P., Connerly, P. L., Tolmasky, M. E., Crosa, J. H., & Actis, L. A. (2004) · Microbiology · doi:10.1099/mic.0.27371-0 · Cited by 135
Li, J., Rayner, C. R., Nation, R. L., Deans, R., Boots, R. J., Widdecombe, N., Douglas, A., & Lipman, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4814-4815.2005 · Cited by 133
Siroy, A., Molle, V., Guillier, C., Vallenet, D., Pestel‐Caron, M., Cozzone, A. J., Jouenne, T., & Dé, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4876-4883.2005 · Cited by 132
al Naiemi, N., Duim, B., Savelkoul, P. H. M., Spanjaard, L., de Jonge, E., Bart, A., Vandenbroucke‐Grauls, C. M. J. E., & de Jong, M. D. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4862-4864.2005 · Cited by 132
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals
Celenza, G., Pellegrini, C., Caccamo, M., Segatore, B., Amicosante, G., & Perilli, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl055 · Cited by 130
Arroyo, L. A. R., García-Curiel, A., Pachón-Ibáñez, M. E., Llanos, A. C., Ruiz, M. T., Pachón, J., & Aznar, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.903-905.2005 · Cited by 130
Héritier, C., Poirel, L., Aubert, D., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.268-273.2003 · Cited by 129
Santillana, E., Beceiro, A., Bou, G., & Romero, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607557104 · Cited by 127
In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain
Betriú, C., Rodríguez-Avial, I., Sánchez, B. A., Gómez, M., Alvarez, J. A. O., & Picazo, J. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.892-895.2002 · Cited by 127
Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin
Tan, T. Y., & Ng, S. Y. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01708.x · Cited by 126
Hasman, H., Kempf, I., Chidaine, B., Cariolet, R., Ersbøll, A. K., Houe, H., Hansen, H. C. B., & Aarestrup, F. M. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.02979-05 · Cited by 124
Kinscherf, T. G., & Willis, D. K. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.13.4133-4136.1999 · Cited by 124
Acinetobacter baumanniiin Human Body Louse
Scola, B. L., & Raoult, D. (2004) · Emerging infectious diseases · doi:10.3201/eid1009.040242 · Cited by 122
Presence of Tetracycline Resistance Determinants and Susceptibility to Tigecycline and Minocycline
Fluit, A. C., Florijn, A., Verhoef, J., & Milatović, D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1636-1638.2005 · Cited by 122
Parenteral and Inhaled Colistin for Treatment of Ventilator-Associated Pneumonia
Linden, P. K., & Paterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504485 · Cited by 122
Self-citationVEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France1
Naas, T., Coignard, B., Carbonne, A., Blanckaert, K., Bajolet, O., Bernet, C., Verdeil, X., Astagneau, P., Desenclos, J., Nordmann, P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1208.051547 · Cited by 122
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Reed, E., Ding, L., Gong, J., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.309 · Cited by 121
Epidemiology and Infection Control Implications of Acinetobacter spp. in Hong Kong
Houang, E. T. S., Chu, Y. W., Leung, E. C., Chu, K. Y., Berlau, J., Ng, K. C., & Cheng, A. F. B. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.228-234.2001 · Cited by 120
Levin, A. S. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00415.x · Cited by 120
Cited by
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Cekanaviciute, E., Yoo, B. B., Runia, T. F., Debelius, J. W., Singh, S., Nelson, C. A., Kanner, R., Bencosme, Y., Lee, Y. K., Hauser, S. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711235114 · Cited by 1,036
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
Metadata
- Authors
- Peleg, A. Y., Seifert, H., & Paterson, D. L.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2008-07
- Volume
- 21
- Issue
- 3
- Pages
- 538-582
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2159435953
- Cited by
- 3,316
- References
- 308
- FWCI
- 50.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.